185 related articles for article (PubMed ID: 24988225)
1. Notch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failure.
Merino H; Singla DK
PLoS One; 2014; 9(7):e101024. PubMed ID: 24988225
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cells improve cardiac function in Doxorubicin-induced cardiomyopathy mediated through multiple mechanisms.
Singla DK; Ahmed A; Singla R; Yan B
Cell Transplant; 2012; 21(9):1919-30. PubMed ID: 22449713
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.
Glass C; Singla DK
Cell Transplant; 2012; 21(9):1931-44. PubMed ID: 22449760
[TBL] [Abstract][Full Text] [Related]
4. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling.
Singla DK; Lyons GE; Kamp TJ
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1308-14. PubMed ID: 17416601
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.
Glass C; Singla DK
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2038-49. PubMed ID: 21856911
[TBL] [Abstract][Full Text] [Related]
6. Akt-mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation.
Singla DK
Cell Transplant; 2015; 24(6):1031-42. PubMed ID: 24594448
[TBL] [Abstract][Full Text] [Related]
7. Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice.
Yan B; Abdelli LS; Singla DK
Mol Pharm; 2011 Oct; 8(5):1602-10. PubMed ID: 21851072
[TBL] [Abstract][Full Text] [Related]
8. Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy.
Singla DK; Johnson TA; Tavakoli Dargani Z
Cells; 2019 Oct; 8(10):. PubMed ID: 31600901
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice.
Chua CC; Gao J; Ho YS; Xu X; Kuo IC; Chua KY; Wang H; Hamdy RC; Reed JC; Chua BH
Cardiovasc Res; 2009 Jan; 81(1):20-7. PubMed ID: 18805781
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart.
Yan B; Singla RD; Abdelli LS; Singal PK; Singla DK
PLoS One; 2013; 8(9):e75580. PubMed ID: 24086577
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem (iPS) cells inhibit apoptosis and fibrosis in streptozotocin-induced diabetic rats.
Neel S; Singla DK
Mol Pharm; 2011 Dec; 8(6):2350-7. PubMed ID: 21988648
[TBL] [Abstract][Full Text] [Related]
12. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
[TBL] [Abstract][Full Text] [Related]
13. Exercise intervention decreases acute and late doxorubicin-induced cardiotoxicity.
Wang F; Chandra J; Kleinerman ES
Cancer Med; 2021 Nov; 10(21):7572-7584. PubMed ID: 34523825
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types.
Singla DK; Hacker TA; Ma L; Douglas PS; Sullivan R; Lyons GE; Kamp TJ
J Mol Cell Cardiol; 2006 Jan; 40(1):195-200. PubMed ID: 16288779
[TBL] [Abstract][Full Text] [Related]
15. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
[TBL] [Abstract][Full Text] [Related]
16. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
17. Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice.
Vedam K; Nishijima Y; Druhan LJ; Khan M; Moldovan NI; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1832-41. PubMed ID: 20363884
[TBL] [Abstract][Full Text] [Related]
18. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
Grant MK; Seelig DM; Sharkey LC; Zordoky BN
Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
[TBL] [Abstract][Full Text] [Related]
19. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
20. Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy.
Silva Dos Santos D; Brasil GV; Ramos IPR; Mesquita FCP; Kasai-Brunswick TH; Christie MLA; Cahli GM; Barbosa RAQ; da Cunha ST; Pereira JX; Medei E; Campos de Carvalho AC; Carvalho AB; Goldenberg RCDS
Stem Cell Res Ther; 2018 Feb; 9(1):30. PubMed ID: 29402309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
